Exercise Hemodynamics and Mitochondrial Oxidative Capacity in Disease Stages of Wild-Type Transthyretin Amyloid Cardiomyopathy

被引:0
|
作者
Ladefoged, Bertil [1 ]
Pedersen, Anders Dahl [1 ]
Seefeldt, Jacob [1 ]
Nielsen, Bent Roni Ranghoj [1 ]
Eiskjaer, Hans [1 ]
Lichscheidt, Emil [1 ]
Clemmensen, Tor [1 ]
Gillmore, Julian David [2 ]
Poulsen, Steen Hvitfeldt [1 ]
机构
[1] Aarhus Univ Hosp, Dept Cardiol, Palle Juul Jensens Blvd 99, DK-8200 Aarhus, Denmark
[2] Royal Free Hosp, Natl Amyloidosis Ctr, London, England
来源
关键词
cardiac amyloidosis; invasive hemodynamics; mitochondrial oxidative phosphorylation; transthyretin amyloid cardiomyopathy; HEART-FAILURE; EJECTION FRACTION; PARAMETERS; RESERVE; FLOW;
D O I
10.1161/JAHA.124.034213
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Wild-type transthyretin amyloid (ATTRwt) cardiomyopathy is increasingly recognized in the development of heart failure. The link between cardiac performance, hemodynamics, and mitochondrial function in disease stages of ATTRwt has not previously been studied but may provide new insights into the pathophysiology and clinical performance of the patients.Methods and Results The study investigated 47 patients diagnosed with ATTRwt at Aarhus University Hospital, Denmark. Patients were stratified according to the disease stages of the National Amyloidosis Centre (NAC) as NAC I with low levels of NT-proBNP (N-terminal pro-B-type natriuretic peptide) (NAC I-L, n=14), NAC I with high levels NT-proBNP (NAC I-H, n=20), and NAC II-III (n=13). Exercise testing with simultaneous right heart catheterization was performed in all patients. Endomyocardial biopsies were collected from the patients and the mitochondrial oxidative phosphorylation capacity was assessed. All NAC disease groups, even in the NAC I-L group, a significant abnormal increase in biventricular filling pressures were noted during exercise while the filling pressures was normal or near normal at rest. The inotropic response to exercise was reduced with diminished increase in cardiac output which was significantly more pronounced in the NAC I-H (Diff. -2.4, 95% CI (-4.2: -0.7), P=0.00) and the NAC II-III group (Diff: -3.1 L/min, 95% CI (-5.2: -1.1), P=0.00) compared with the NAC I-L group. The pulmonary artery wedge pressure to cardiac output ratio at peak exercise was significantly different between NAC I-L and NAC II-III (Diff: 1.6 mm Hg*min/L, 95% CI (0.01:3.3, P=0.04)). Patients with ATTRwt had a reduced oxidative phosphorylation capacity which correlated to left ventricular mass but not to cardiac output capacity.Conclusions An abnormal restrictive left ventricle and right ventricle response to exercise was demonstrated, even present in patients with early-stage ATTRwt. In more advanced disease stages a progressive impairment of the pressure-flow relationship was noted. The myocyte energetics is deranged but not associated to the contractile reserve or restrictive filling characteristics in ATTRwt.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Wild-Type Transthyretin Amyloid Cardiomyopathy: The Gordian-Knot of Novel Therapeutic Regimens
    Zegkos, Thomas
    Gossios, Thomas
    Ntelios, Dimitris
    Parcharidou, Despoina
    Karvounis, Haralampos
    Efthimiadis, Georgios
    [J]. CARDIOLOGY IN REVIEW, 2023, 31 (01) : 36 - 41
  • [32] Multiparametric Monitoring of Disease Progression in Contemporary Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy Initiating Tafamidis Treatment
    Ney, Svenja
    Gertz, Roman Johannes
    Pennig, Lenhard
    Nies, Richard J.
    Holtick, Udo
    Voelker, Linus A.
    Wunderlich, Gilbert
    Seuthe, Katharina
    Hohmann, Christopher
    Metze, Clemens
    Nahle, Claas Philip
    von Stein, Jennifer
    Bruewer, Monique
    ten Freyhaus, Henrik
    Pfister, Roman
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [33] Recovery of sinus rhythm by tafamidis in patients with wild-type transthyretin amyloid cardiomyopathy with atrial arrhythmias
    Isotani, Yoshitaka
    Amiya, Eisuke
    Ishida, Junichi
    Ishizuka, Masato
    Hatano, Masaru
    Nakanishi, Koki
    Daimon, Masao
    Komuro, Issei
    [J]. OXFORD MEDICAL CASE REPORTS, 2022, 2022 (02):
  • [34] LEFT ATRIAL RESERVOIR AND STIFFNESS IN PATIENTS WITH WILD-TYPE TRANSTHYRETIN AMYLOID VS HYPERTROPHIC CARDIOMYOPATHY
    Campisi, Mariapaola
    Trimarchi, Giancarlo
    De Sarro, Rosalba
    Poleggi, Cristina
    Luongo, Alfredo
    Teresi, Lucio
    Lofrumento, Francesca
    Restelli, Davide
    Recupero, Antonino
    Zito, Concetta
    Di Bella, Gianluca
    De Gregorio, Cesare
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
  • [35] Survival Benefit With Higher Dose Tafamidis in Patients With Hereditary and Wild-type Transthyretin Amyloid Cardiomyopathy
    Shah, Sanjiv J.
    Gundapaneni, Balarama
    Sultan, Marla B.
    Merlini, Giampaolo
    [J]. CIRCULATION, 2020, 142
  • [36] Implementing clinical pathways to enable early diagnosis and treatment of wild-type transthyretin amyloid cardiomyopathy
    Muller, Steven A.
    Oerlemans, Marish I. F. J.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (06) : 854 - 856
  • [37] Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy
    Porcari, Aldostefano
    Razvi, Yousuf
    Masi, Ambra
    Patel, Rishi
    Ioannou, Adam
    Rauf, Muhammad U.
    Hutt, David F.
    Rowczenio, Dorota
    Gilbertson, Janet
    Martinez-Naharro, Ana
    Venneri, Lucia
    Whelan, Carol
    Lachmann, Helen
    Wechalekar, Ashutosh
    Quarta, Candida Cristina
    Merlo, Marco
    Sinagra, Gianfranco
    Hawkins, Philip N.
    Fontana, Marianna
    Gillmore, Julian D.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (04) : 515 - 524
  • [38] Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy
    Porcari, A.
    Razvi, Y.
    Masi, A.
    Patel, R.
    Ioannou, A.
    Rauf, M. U.
    Venneri, L.
    Martinez-Naharro, A.
    Merlo, M.
    Sinagra, G.
    Lachmann, H.
    Wechalekar, A.
    Hawkins, P. N.
    Fontana, M.
    Gillmore, J. D.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 356 - 356
  • [39] Right ventricular-dominant transthyretin deposition: an early stage or a rare phenotype of wild-type transthyretin amyloid cardiomyopathy?
    Hata, Satoshi
    Ota, Shingo
    Tanaka, Atsushi
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2023, 24 (06) : E99 - E99
  • [40] Acute aortic dissection associated with wild-type transthyretin amyloid
    Mori, Shinichiro
    Hatae, Ryusuke
    Iwaki, Toru
    [J]. PATHOLOGY INTERNATIONAL, 2021, 71 (08) : 556 - 558